Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05264376 · ClinicalTrials.gov registry record · NA

Eating Disorder Prevention Program for Women With T1D

A NA study of Type 1 Diabetes and Eating Disorders, sponsored by Stanford University.

Completed
Registry status
NA
Development phase
55
Enrollment target
1
Study location

NCT05264376 is a NA study of Type 1 Diabetes and Eating Disorders that has completed, run by Stanford University. The registered enrollment target is 55 participants, below the 824-participant average among 178 other Type 1 Diabetes trials with a reported enrollment target (93% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05264376, a NA study of Type 1 Diabetes and Eating Disorders, has completed, sponsored by Stanford University.

COMPLETED
Registry status
NA
Development phase
55 participants
Enrollment target
1
Study location

Study Summary

This study aims to test the effectiveness of an evidence-based eating- disorder prevention program specifically targeted for individuals with Type 1 Diabetes (T1D) compared to an educational control group. The Diabetes Body Project (DBP), is an adaptation of the Body Project which is the only eating disorder prevention program to have repeatedly produced effects when evaluated by independent researchers, produced stronger effects than credible alternative interventions, and affected objective outcomes. DBP has been adapted slightly for individuals with T1D who are at ultra-high risk for eating disorders. The study aims to test the effectiveness of the DBP of reducing body image concerns and reducing eating pathology and improving glycemic control.

Interventions

  • BEHAVIORAL Diabetes Body Project
  • BEHAVIORAL Educational Control

Study Locations (1)

California

  • Stanford University - Stanford

Trial Details

FieldValue
Enrollment Target 55 participants
Start Date 2022-03-21
Est. Completion 2023-04-15
Phase NA

Sponsor

Stanford University

1,744 total trials

What the Registry Record Tells You About NCT05264376

The ClinicalTrials.gov registry entry for NCT05264376 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 55 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 824-participant average among 178 other Type 1 Diabetes trials with a reported enrollment target (93% lower). The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Type 1 Diabetes appearing as the primary indexed condition, and to 2 interventions - of which Diabetes Body Project is the first listed.

NCT05264376 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT05264376 about?

NCT05264376 is a clinical study titled "Eating Disorder Prevention Program for Women With T1D". This study aims to test the effectiveness of an evidence-based eating- disorder prevention program specifically targeted for individuals with Type 1 Diabetes (T1D) compared to an educational control group. The Diabetes Body Project (DBP), is an adaptation of the Body Project which is the only eating...

What is the current status of trial NCT05264376?

This trial is currently completed. It is a NA study. The enrollment target is 55 participants. The study started on 2022-03-21. Estimated completion is 2023-04-15.

What conditions does trial NCT05264376 study?

This clinical trial studies the following conditions: Type 1 Diabetes, Eating Disorders.

What interventions are being tested in trial NCT05264376?

The interventions under investigation include: Diabetes Body Project (BEHAVIORAL), Educational Control (BEHAVIORAL).

Who is sponsoring clinical trial NCT05264376?

This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05264376 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Type 1 Diabetes

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.